We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 4500C
GlaxoSmithKline PLC
19 January 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === =========================================================== a) Name Mr N Hirons === ====================== =================================== b) Position/status SVP, Global Ethics & Compliance === ====================== =================================== c) Initial notification/ Initial notification amendment === ====================== =================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =========================================================== a) Name GlaxoSmithKline plc === ====================== =================================== b) LEI 5493000HZTVUYLO1D793 === ====================== =================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =========================================================== a) Description GlaxoSmithKline plc American of the financial Depositary Shares ('ADSs') instrument ISIN: US37733W1053 === ====================== =================================== b) Nature of Acquisition of ADSs following the transaction the re-investment of dividends paid to shareholders on 11 January 2018. === ====================== =================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $38.0676 19.625 --------- ---------- === ====================== =================================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== =================================== e) Date of the 2018-01-18 transaction === ====================== =================================== f) Place of the New York Stock Exchange (XNYS) transaction === ====================== =================================== 1. Details of PDMR/person closely associated with them ('PCA') === =========================================================== a) Name Mr B McNamara === ====================== =================================== b) Position/status CEO, Consumer Healthcare === ====================== =================================== c) Initial notification/ Initial notification amendment === ====================== =================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =========================================================== a) Name GlaxoSmithKline plc === ====================== =================================== b) LEI 5493000HZTVUYLO1D793 === ====================== =================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =========================================================== a) Description American Depositary Shares ('ADSs') of the financial ISIN: US37733W1053 instrument === ====================== =================================== b) Nature of Acquisition of ADSs following the transaction the re-investment of dividends paid to shareholders on 11 January 2018. === ====================== =================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $38.0676 232.515 --------- ---------- === ====================== =================================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== =================================== e) Date of the 2018-01-18 transaction === ====================== =================================== f) Place of the New York Stock Exchange (XNYS) transaction === ====================== =================================== 1. Details of PDMR/person closely associated with them ('PCA') === =========================================================== a) Name Mr D E Troy === ====================== =================================== b) Position/status SVP & General Counsel === ====================== =================================== c) Initial notification/ Initial notification amendment === ====================== =================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =========================================================== a) Name GlaxoSmithKline plc === ====================== =================================== b) LEI 5493000HZTVUYLO1D793 === ====================== =================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =========================================================== a) Description American Depositary Shares ('ADSs') of the financial ISIN: US37733W1053 instrument === ====================== =================================== b) Nature of Acquisition of ADSs following the transaction the re-investment of dividends paid to shareholders on 11 January 2018. === ====================== =================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $38.0676 1826.446 --------- ---------- === ====================== =================================== d) Aggregated n/a (single transaction) information Aggregated volume Price === ====================== =================================== e) Date of the 2018-01-18 transaction === ====================== =================================== f) Place of the New York Stock Exchange (XNYS) transaction === ====================== ===================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDKLFFVFFFBBZ
(END) Dow Jones Newswires
January 19, 2018 12:17 ET (17:17 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions